Heparin-induced thrombocytopenia resident survival guide: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
Line 32: | Line 32: | ||
❑ Abscence of petechiae and/or significant bleeding<br> </div>}} | ❑ Abscence of petechiae and/or significant bleeding<br> </div>}} | ||
{{familytree | | | | | | | | | | | | |!| | | | | | | | | | | | | | | | | | | | | | | | | | | |}} | {{familytree | | | | | | | | | | | | |!| | | | | | | | | | | | | | | | | | | | | | | | | | | |}} | ||
{{familytree | | | | | | | | | | | | B01 | | | | | | | | | | | | | | | | | | | | | | | | | | | | {{familytree | | | | | | | | | | | | | | | |)|-| B01 |-| B02 | | | |B01= |B02= }} | ||
{{familytree | | | | | | | | | | | | | | | |!| | | | | | | | | | | | | | | | | | }} | |||
{{familytree | | | | | | | | | | | | C01 |-|+|-| C02 |-| C03 | | | |C01= |C02= |C03= }} | |||
{{familytree | | | | | | | | | | | | | | | |!| | | | | | | | | | | | | | | | | | }} | |||
{{familytree | | | | | | | | | | | | | | | |)|-| D01 |-| D02 | | | |D01= |D02= }} | |||
{{familytree | | | | | | | | | | | | |!| | | | | | | | | | | | | | | | | | | | | | | | | | | |}} | {{familytree | | | | | | | | | | | | |!| | | | | | | | | | | | | | | | | | | | | | | | | | | |}} | ||
{{familytree | | | | | | | | | | | | M01 | | | | | | | | | | | | | | | | | | | | | | | | | | |M01='''Initiate alternative antocoagulant therapy for at least 2- 3 months''' <br><div style="float: left; text-align: left; line-height: 150% "> </div>}} | {{familytree | | | | | | | | | | | | M01 | | | | | | | | | | | | | | | | | | | | | | | | | | |M01='''Initiate alternative antocoagulant therapy for at least 2- 3 months''' <br><div style="float: left; text-align: left; line-height: 150% "> </div>}} |
Revision as of 08:59, 31 December 2013
Resident Survival Guide |
---|
Introduction |
Team |
Guide |
Page Template |
Examine the Patient Template |
Navigation Bar Template |
Checklist |
Topics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Karol Gema Hernandez, M.D. [2]
Definition
This section provides a short and straight to the point definition of the disease or symptom in one sentence.
Causes
Life Threatening Causes
Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated.
Common Causes
Management
Shown below is an algorithm summarizing the approach to heparin induced thrombocytopenia.
}}Thrombocytopenia: ❑ Platelet count <150,000/mm3 or ❑ >50% decrease from highest level before initiation of heparin therapy ❑ Making sure patient has received heparin or LMWH in the previous 5- 14 days ❑ And after ruling out other causes of thrombocytopenia | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
High or intermediate clinical suspicion of HIT ❑ Venous/arterial thrombosis ❑ Unusual manifestations:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Initiate alternative antocoagulant therapy for at least 2- 3 months | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Proceed to serologic testing | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Positive + high clinical suspicion of HIT | Positive + intermediate suspicion of HIT | Negative + high clinical suspicion of HIT | Negative + intermediate clinical suspicion of HIT | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Confirmed HIT | Proceed to functional testing | Indeterminate HIT | Can restart heparin | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Rule out other causes of thrombocytopenia | Rule out other causes of thrombocytopenia | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||